20
NPS Score
VS
NGM Biopharmaceuticals Claimed Company
- EMPLOYEE
PARTICIPANTS - 10
- TOTAL
RATINGS
Revance Therapeutics Claimed Company
- EMPLOYEE
PARTICIPANTS - 21
- TOTAL
RATINGS
NGM Biopharmaceuticals vs Revance Therapeutics
Compare NGM Biopharmaceuticals versus Revance Therapeutics for CEO Rating, Overall Culture Score, Brand Ranking, and other ratings. Results were generated by 10 employees and customers of NGM Biopharmaceuticals and 21 employees and customers of Revance Therapeutics.
NGM Biopharmaceuticals
NGM Biopharmaceuticals's brand is ranked #- in the list of Global Top 1000 Brands, as rated by customers of NGM Biopharmaceuticals. Their current market cap is $280.84M.
Revance Therapeutics
Revance Therapeutics's brand is ranked #- in the list of Global Top 1000 Brands, as rated by customers of Revance Therapeutics. Their current market cap is $2.39B.
3.2/5
Product Quality
4.2/5
4.1/5
Pricing
4.2/5
5/5
Customer Service
4.1/5
| 60% | Promoters |
|---|---|
| 0% | Passive |
| 40% | Detractors |
65
NPS Score
| 79% | Promoters |
|---|---|
| 7% | Passive |
| 14% | Detractors |
Net Promoter Score
Winner by 45
See how NGM Biopharmaceuticals compares to its competitors
Working at NGM Biopharmaceuticals vs Working at Revance Therapeutics
86 / 100
CEO Rating
Winner by 27%
59 / 100
CEO Rating
NGM Biopharmaceuticals
NGM Biopharmaceuticals doesn't have enough ratings to calculate the Team Culture Ratings.
Know someone that works there? Invite them to rate their experience.
Revance Therapeutics
Employees at Revance Therapeutics rate their CEO, Mark Foley, 59/100. This score is 27% lower than the scores of NGM Biopharmaceuticals' CEO, David Woodhouse.